Literature DB >> 3435117

Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.

Y Kita1, A Imada.   

Abstract

The mechanism of the renal excretion of carumonam (CRMN) was investigated in rats, rabbits, dogs, and monkeys. Stop-flow analysis in dogs demonstrated that CRMN is exclusively excreted by glomerular filtration. There was no specific CRMN peak corresponding to the peak of p-aminohippuric acid (PAH) secretion or to the trough of Na+-K+ reabsorption in the stop-flow pattern. Although the PAH peak disappeared when probenecid was administered, the CRMN stop-flow pattern showed no change. In rabbits, however, the CRMN concentration peak corresponding with the PAH peak was detected in the stop-flow pattern; the CRMN peak disappeared when probenecid was administered. The pharmacokinetic parameters in plasma, such as the area under the concentration-time curve, the half-life, and the clearance rate, were affected by probenecid in rats, rabbits, and monkeys, but not in dogs. The results suggest that the renal excretion of CRMN in dogs takes place exclusively through glomerular filtration. In rats, rabbits, and monkeys, however, CRMN is excreted through both glomerular filtration and renal tubular secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435117      PMCID: PMC175022          DOI: 10.1128/AAC.31.11.1692

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Localization of nephron transport by stop flow analysis.

Authors:  R L MALVIN; W S WILDE; L P SULLIVAN
Journal:  Am J Physiol       Date:  1958-07

2.  Determination of inulin by means of resorcinol.

Authors:  G E SCHREINER
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

3.  Simplified measurement of p-aminohippurate and other arylamines in plasma and urine.

Authors:  W H Waugh; P T Beall
Journal:  Kidney Int       Date:  1974-06       Impact factor: 10.612

4.  Preparation of mean drug concentration--time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters.

Authors:  E Mizuta; A Tsubotani
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-04       Impact factor: 1.645

5.  In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.

Authors:  A Imada; M Kondo; K Okonogi; K Yukishige; M Kuno
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  [Mechanism of renal excretion of ceftizoxime in rabbits and dogs (author's transl)].

Authors:  T Murakawa; S Nakamoto; M Nishida
Journal:  Jpn J Antibiot       Date:  1980-06

7.  Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.

Authors:  K Yoshida; M Mitani; I Naeshiro; H Torii; S Tanayama
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

8.  Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.

Authors:  Y Kita; T Fugono; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

9.  Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis.

Authors:  J Shimada; T Yamaji; T Miyahara; Y Ueda; T Kawabata; K Sugeno; T Yoshida; M Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.

Authors:  E Weidekamm; K Stoeckel; H J Egger; W H Ziegler
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.